Clinical Trials Browser

Phase 2 × Neoplasms × lutetium Lu 177 dotatate × Clear all

NCT07012330 2025-06-10

Comparing 177Lu-Dotatate/Capecitabine Combination Treatment With 177Lu-Dotatate in Neuroendocrine Tumor Patients

Phase 2 Terminated

Neoplasms, Neuroendocrine Tumors